Fortrea sells pair of businesses to private equity firm to become 'pure-play' CRO AI is already widely used in drug development and is advancing into clinical trials, too, as evidenced by the many ...

Gainey McKenna & Egleston has filed a class action lawsuit against Fortrea over claims that it misled investors about revenue ...

Fortrea is poised to benefit from steadily increasing levels of outsourced clinical trials and complex novel therapeutics, such as biologics and gene therapies. Fortrea has extensive experience ...

However, the nuts and bolts of clinical trials are rooted in quite traditional methods and processes. Fortrea aims to modernize the way clinical trials are run with innovation that combines the ...

Fortrea is poised to benefit from steadily increasing levels of outsourced clinical trials and complex novel therapeutics, such as biologics and gene therapies. Fortrea has extensive experience ...

Fortrea, a recent Labcorp spin-off ... According to this March 2024 article by PharmaExec.com, new clinical trials were down 15% in 2023 from 2022 and down 21% in 2023 from 2021 The article ...

There are a number of sources of information on clinical trials, most of which are designed for patients. One of the best places to start is ClinicalTrials.gov, which is run by the National ...

DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) — The Society for Clinical Research Sites (SCRS) and Fortrea (Nasdaq ... to make sites more sustainable and trials more efficient—ultimately ...

Spun off from Labcorp in 2023, Fortrea Holdings (NASDAQ:FTRE) provides contract research and development services for pharmaceutical and biotechnology companies, specializing in clinical trials ...

Fortrea (NASDAQ:FTRE) is a contract research organization that helps pharmaceutical, biotech, and medical device companies develop and bring their products to market through clinical trials and ...

Clinical trials are an essential part of medical breakthroughs that help patients, but getting them off the ground and running them is often fraught with challenges. Specifically, qualification ...

“We are excited to partner with SCRS to launch and support this working group,” said Mike Clay, senior vice president of Global Project Delivery at Fortrea. “Clinical trials are becoming increasingly ...